Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs SPDR Kensho Final Frontiers ETF (ROKT) Price & Performance

Hims and Hers Health IncTrade
SPDR Kensho Final Frontiers ETFTrade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs SPDR Kensho Final Frontiers ETF — how do they compare? Hims and Hers Health Inc trades at $28.32 (market cap $6.89B), while SPDR Kensho Final Frontiers ETF trades at $102.84 (market cap $176.19M). The key difference: Hims and Hers Health Inc is far larger — about 39.1× SPDR Kensho Final Frontiers ETF's market cap, and SPDR Kensho Final Frontiers ETF is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and SPDR Kensho Final Frontiers ETF for 8 Days on average.

HIMSROKT
Market Cap
$6.89B$176.19M
Volume
5,446,62834,479
Sector
HealthSector/Thematic
52-Week High
$62.76$136.68
52-Week Low
$14.52$72.93
Typical Hold Time
21 Days8 Days
Enterprise Value
$7.60B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

Hims & Hers Health trades at $29.54, up 0.24% on the day, with a bullish technical signal from moving averages but mixed earnings performance. Revenue grew to $2.35 billion in 2025, yet the company posted a net loss of $142 million in 2026, reflecting profitability challenges. High valuation ratios like a P/E of 57.14 and negative ROE of -32.03% indicate premium pricing despite weak earnings. Recent news highlights multiple securities class action lawsuits filed in October 2026, creating legal overhangs.

The stock faces headwinds from profitability struggles and legal risks, but analyst consensus remains a Buy with a $32.17 price target, suggesting modest upside. Investment appeal hinges on resolving operational inefficiencies and legal issues to align valuation with fundamentals, while current sentiment is cautious due to recent earnings misses and regulatory scrutiny.

SPDR Kensho Final Frontiers ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HIMS
86% Buy14% Sell
Avg holding period · 21 Days
ROKT

No sentiment data available yet.

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS →

About SPDR Kensho Final Frontiers ETF

SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.

Read more on ROKT →